Skip to main content
. 2016 Sep 28;7(44):71703–71709. doi: 10.18632/oncotarget.12323

Table 2. Patient, treatment, and follow-up information.

Patient characteristic No. (%) No. of deaths Survival times Cumulative proportion of patients surviving after the indicated time P HR (95.0% CI)
Median ± SE Estimate ± SE
1 year 3 years 5 years
Age < 60 80 (47.1) 47 73.00 ± 11.30 0.88 ± 0.04 0.597 ± 0.055 0.49 ± 0.06
≥ 60 90 (52.9) 53 30.00 ± 4.43 0.82 ± 0.04 0.574 ± 0.053 0.45 ± 0.06 1.161 0.78(1.72~0.46)
Differentiation well differentiated 31 (18.2) 18 71.00 ± 28.29 0.87 ± 0.06 0.541 ± 0.091 0.50 ± 0.09 0.011*
moderately differentiated 125 (73.5) 70 59.00 ± 10.13 0.87 ± 0.03 0.620 ± 0.044 0.49 ± 0.05 0.794 0.93(0.56 ~1.57)
poorly differentiated 14 (8.2) 12 15.00 ± 9.35 0.57 ± 0.13 0.214 ± 0.110 0.21 ± 0.11 0.020* 2.40 (1.15~ 5.00)
Clinical stages T1-T2 102 (60.0) 52 77.00 ± 10.62 0.91 ± 0.03 0.663 ± 0.047 0.59 ± 0.05
T3-T4 68 (40.0) 48 32.00 ± 4.97 0.75 ± 0.05 0.437 ± 0.061 0.30 ± 0.06 0.000* 2.17(1.45 ~3.25)
N0 116 (68.3) 61 71.00 ± 11.59 0.90 ± 0.03 0.670 ± 0.044 0.67 ± 0.04
N1-N2 54 (31.8) 39 26.00 ± 6.08 0.74 ± 0.06 0.361 ± 0.067 0.30 ± 0.07 0.000* 2.39(1.58~3.62)
I-II 73 (42.9) 30 98.00 ± 15.57 0.97 ± 0.02 0.763 ± 0.050 0.69 ± 0.06
III-IV 97 (57.1) 70 32.00 ± 3.98 0.753 ± 0.04 0.429 ± 0.051 0.30 ± 0.05 0.000* 3.30 (2.10~5.18)
Treatment Partial laryngectomy 104 (61.2) 50 73.00 ± 11.30 0.904 ± 0.03 0.678 ± 0.046 0.58 ± 0.05
Total laryngectomy 66 (38.8) 50 30.00 ± 4.43 0.76 ± 0.05 0.405 ± 0.061 0.30 ± 0.06 0.000* 2.35 (1.58 ~3.49)
cervical lymph node dissection 37 (21.8) 19 0.270 ± 0.06 0.47 ± 0.09 0.47 ± 0.09
no cervical lymph node dissection 133 (78.2) 81 56.00 ± 10.04 0.89 ± 0.03 0.60 ± 0.04 0.48 ± 0.05 0.19 0.71(0.43 ~1.19)

Note:

*

P < 0.05.